Ochradenus arabicus
Ochradenus arabicus · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Ochradenus arabicus is a notable plant species that has become a focal point for pharmacological research due to its diverse biological activities. Recent studies have specifically investigated the cytotoxic potential of its leaves through various forms, including volatile oils and crude ethanolic extracts. When tested in vitro, these preparations have demonstrated significant effects on cellular stability and health. The plant's extracts are evaluated for their ability to induce apoptosis and trigger various forms of DNA damage. Furthermore, research focuses on how these components influence chromosomal aberration and catalase enzyme levels within targeted cells.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Resedaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Taxonomy
Ochradenus arabicus is a distinctive member of the kingdom Plantae. Within this vast biological kingdom, the species belongs to the class Equisetopsida. It is further classified under the order Brassicales, showcasing its evolutionary connections. As part of the Resedaceae family, it shares specific botanical traits with its close relatives. Ultimately, this plant is defined by its placement within the genus Ochradenus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Brassicales |
| Family | Resedaceae |
| Genus | Ochradenus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ochradenus arabicus is a resilient species primarily distributed across the temperate regions of Asia. Its presence is most notable throughout the Arabian Peninsula, where it thrives in various local environments. Specifically, the plant can be found across the Gulf States, including Oman, Saudi Arabia, and Yemen. Beyond the peninsula, its range extends into Western Asia, particularly within the country of Iran. This widespread distribution highlights the plant's ability to adapt to the diverse landscapes of the Middle East.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ochradenus arabicus is characterized by its distinctive growth form as a shrub.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Ochradenus arabicus has demonstrated notable cytotoxic activity according to recent biological assessments. Researchers utilized the MTT cell viability assay to evaluate the crude ethanolic extract of the plant against MCF-7 adenocarcinoma breast cancer cells. The results indicated that the extract possesses a moderate level of toxicity toward these specific cancer cells. Beyond its cytotoxic properties, the plant also showed significant antioxidant potential by reducing oxidative stress induced by doxorubicin. These findings suggest that while the species holds promise, further investigation is required to determine its viability as a chemotherapeutic agent.
Compounds
Ochradenus arabicus contains a diverse array of bioactive compounds within its volatile oils. Research indicates that isothiocyanates serve as one of the primary chemical components in both male and female plants. Specifically, the species contains butyl isothiocyanate and isobutyl isothiocyanate, which contribute to its chemical profile. Furthermore, the presence of terpenes is a significant characteristic of its volatile oil composition. Other notable constituents identified in the plant include carvone, which varies in concentration depending on the gender of the specimen.
Conditions
Ochradenus arabicus demonstrates significant medicinal potential by effectively treating DNA damage and mitigating the harmful effects of genotoxicity. The plant's extracts exhibit cytotoxic properties that allow it to treat MCF-7 adenocarcinoma breast cancer cells. It further serves as a powerful antioxidant by treating reactive oxygen species (ROS) and reducing lipid peroxidation. This plant also treats oxidative stress by increasing antioxidant enzyme activities, such as superoxide dismutase and reduced glutathione. Additionally, the therapeutic applications of Ochradenus arabicus include the ability to treat apoptosis induced by cytotoxic agents.
Preparations
Ochradenus arabicus is prepared as volatile oils to study the chemical variations and allelopathic activities between male and female plants. The species is also prepared as a crude ethanolic extract to evaluate its cytotoxic and antioxidant potential against MCF-7 breast cancer cells. Researchers further utilize the plant as an ethanolic extract for UPLC-MS based chromatographic profiling of its bioactive compounds. In laboratory settings, Ochradenus arabicus is prepared as in vitro raised shoots to assess the impact of phytomediated zinc oxide nanoparticles on growth and oxidative stress. Finally, the plant is managed in vitro to facilitate conservation and the production of multiple shoots for secondary metabolite harvesting.
Parts used
Ochradenus arabicus serves as a vital biological resource in the synthesis of various metallic nanoparticles. Research highlights that the leaves of this medicinal plant are specifically utilized to create green-synthesized silver and zinc oxide nanoparticles. These leaf extracts provide a sustainable method for producing nanomaterials that can significantly influence plant physiology. For instance, nanoparticles derived from these leaves have been shown to enhance biomass and antioxidant enzyme activities in Maerua oblongifolia. Furthermore, the bioactive components within the Ochradenus arabicus leaf extract offer potential medicinal benefits by ameliorating cytotoxicity in biological models.